IL17RA (Interleukin-17 receptor A) variants and mutations
IL17RA (also known as Interleukin-17 receptor A) is a human protein-coding gene encoding an interleukin-17 receptor A protein. It is required for cellular responses to IL-17A and IL-17F, linking T-cell signals to epithelial antimicrobial defense. Biallelic loss-of-function variants can cause chronic mucocutaneous candidiasis through defective mucosal antifungal immunity. This analysis covers 1,432 IL17RA variants and mutations. Of these, 85% have computational variant effect predictions. Disease context includes immunodeficiency 51, psoriasis, and Chronic mucocutaneous candidosis. Example IL17RA variants include G2R, G2V, and G2W.
Variant analysis overview
- Gene: IL17RA
- Protein: Interleukin-17 receptor A
- UniProt accession: Q96F46
- Organism: Homo sapiens
- Variants analyzed: 1432
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 1,211 unspecified-consequence records; 128 missense variants; 72 synonymous variants; 2 in-frame insertions; 6 stop-gained variants; 3 in-frame deletions; 6 frameshift variants; 4 splice-region variants
- Prediction scores: 1,214 variants have prediction scores (85% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: immunodeficiency 51, psoriasis, Chronic mucocutaneous candidosis, psoriasis vulgaris, psoriatic arthritis, pustular psoriasis, chronic mucocutaneous candidiasis, COVID-19, immune system disorder, systemic sclerosis, ankylosing spondylitis, palmoplantar pustulosis.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 1 domains; 9 post-translational modification sites.
- Structural context: 239 variants have structural context.
- PTM context: 13 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable IL17RA variants
Examples include G2R, G2V, G2W, G2E, G2G, A3T, A3V, A3S. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- G2R (p.Gly2Arg), gnomAD rs113670534, REVEL 0.06, MetaLR 0.01
- G2V (p.Gly2Val), gnomAD rs1181895942, REVEL 0.06, MetaLR 0.01
- G2W (p.Gly2Trp), gnomAD rs113670534, REVEL 0.11, MetaLR 0.03
- G2E (p.Gly2Glu), gnomAD 22-17085096-G-A, REVEL 0.08, MetaLR 0.01
- G2G (p.Gly2Gly), rs1410420542, gnomAD 22-17085097-G-A, CADD 8.34
- A3T (p.Ala3Thr), gnomAD rs1471204985, REVEL 0.03, MetaLR 0.01
- A3V (p.Ala3Val), rs567320041, ClinGen CA321139713, ClinVar RCV000799938, 1000Genomes rs567320041, REVEL 0.02, MetaLR 0.01, Uncertain significance, Immunodeficiency 51
- A3S (p.Ala3Ser), gnomAD 22-17085098-G-T, REVEL 0.07, MetaLR 0.01
- A3G (p.Ala3Gly), gnomAD 22-17085099-C-G, REVEL 0.08, MetaLR 0.01
- A3D (p.Ala3Asp), gnomAD 22-17085099-C-A, REVEL 0.10, MetaLR 0.01
- A3A (p.Ala3Ala), rs1358603788, gnomAD 22-17085100-C-A, CADD 5.80
- A4E (p.Ala4Glu), gnomAD rs1300159939, REVEL 0.01, MetaLR 0.01
- A4S (p.Ala4Ser), TOPMed rs1464593132, gnomAD rs1464593132, REVEL 0.03, MetaLR 0.01, Uncertain significance, not specified
- A4T (p.Ala4Thr), TOPMed rs1464593132, gnomAD rs1464593132, REVEL 0.03, MetaLR 0.01
- A4P (p.Ala4Pro), gnomAD 22-17085101-G-C, REVEL 0.08, MetaLR 0.01
- A4V (p.Ala4Val), gnomAD 22-17085102-C-T, REVEL 0.04, MetaLR 0.01
- A4A (p.Ala4Ala), gnomAD 22-17085103-A-T, CADD 8.84
- R5C (p.Arg5Cys), rs1351337413, ClinGen CA410210081, ClinVar RCV001912005, TOPMed rs1351337413, REVEL 0.01, MetaLR 0.02, Uncertain significance, Immunodeficiency 51
- R5G (p.Arg5Gly), TOPMed rs1351337413, gnomAD rs1351337413, REVEL 0.03, MetaLR 0.02, Uncertain significance
- R5H (p.Arg5His), gnomAD rs1410266278, REVEL 0.06, MetaLR 0.02
- R5S (p.Arg5Ser), TOPMed rs1351337413, gnomAD rs1351337413, REVEL 0.01, MetaLR 0.02, Uncertain significance
- R5L (p.Arg5Leu), gnomAD 22-17085105-G-T, REVEL 0.03, MetaLR 0.02
- R5R (p.Arg5Arg), rs2061321115, gnomAD 22-17085106-C-T, CADD 6.63
- S6N (p.Ser6Asn), rs2061321130, ClinGen CA410210089, ClinVar RCV003087901, REVEL 0.01, MetaLR 0.01, Uncertain significance, Immunodeficiency 51
- S6R (p.Ser6Arg), TOPMed rs988752151, gnomAD rs988752151, REVEL 0.03, MetaLR 0.01, Likely benign
- S6T (p.Ser6Thr), rs2061321130, ClinGen CA410210090, ClinVar RCV004315761, Ensembl rs2061321130, REVEL 0.01, MetaLR 0.01, Uncertain significance, not specified
- S6G (p.Ser6Gly), gnomAD 22-17085107-A-G, REVEL 0.07, MetaLR 0.01
- S6I (p.Ser6Ile), gnomAD 22-17085108-G-T, REVEL 0.01, MetaLR 0.01
- S6S (p.Ser6Ser), rs988752151, gnomAD 22-17085109-C-T, CADD 7.47
- P7A (p.Pro7Ala), 1000Genomes rs534399492, ExAC rs534399492, TOPMed rs534399492, gnomAD rs534399492, REVEL 0.02, MetaLR 0.01, Likely benign
- P7L (p.Pro7Leu), rs143652002, ClinGen CA10086205, cosmic curated COSV60055, ClinVar RCV000533617, REVEL 0.01, MetaLR 0.01, Likely benign, Immunodeficiency 51; not provided
- P7Q (p.Pro7Gln), 1000Genomes rs143652002, ExAC rs143652002, TOPMed rs143652002, gnomAD rs143652002, REVEL 0.02, MetaLR 0.01, Uncertain significance, Immunodeficiency 51
- P7S (p.Pro7Ser), rs534399492, ClinGen CA10086204, ClinVar RCV000886918, ClinVar RCV004773208, REVEL 0.01, MetaLR 0.01, Conflicting interpretations, not provided; Immunodeficiency 51
- P7T (p.Pro7Thr), gnomAD 22-17085110-C-A, REVEL 0.01, MetaLR 0.01
- P7P (p.Pro7Pro), gnomAD 22-17085112-G-A, CADD 4.92
- P8L (p.Pro8Leu), rs2123786576, ClinGen CA410210102, ClinVar RCV002034997, ClinVar RCV005851926, REVEL 0.02, MetaLR 0.02, Uncertain significance, not specified; Immunodeficiency 51
- P8T (p.Pro8Thr), gnomAD 22-17085113-C-A, REVEL 0.03, MetaLR 0.02
- P8S (p.Pro8Ser), gnomAD 22-17085113-C-T, REVEL 0.03, MetaLR 0.02
- P8Q (p.Pro8Gln), gnomAD 22-17085114-C-A, REVEL 0.07, MetaLR 0.03
- P8P (p.Pro8Pro), rs1278738062, gnomAD 22-17085115-G-A, CADD 2.08
- S9F (p.Ser9Phe), rs752407403, ClinGen CA10086206, ClinVar RCV000796551, ExAC rs752407403, REVEL 0.01, MetaLR 0.01, Uncertain significance, Immunodeficiency 51
- p.Ser9dup, gnomAD 22-17085113-C-CCG, CADD 10.60
- S9P (p.Ser9Pro), gnomAD 22-17085116-T-C, REVEL 0.01, MetaLR 0.01
- S9Y (p.Ser9Tyr), gnomAD 22-17085117-C-A, REVEL 0.01, MetaLR 0.01
- S9S (p.Ser9Ser), gnomAD 22-17085118-C-A, CADD 4.86
- A10T (p.Ala10Thr), 1000Genomes rs758765484, ExAC rs758765484, TOPMed rs758765484, gnomAD rs758765484, REVEL 0.02, MetaLR 0.01
- A10* (p.Ala10Ter), gnomAD 22-17085117-C-CGT, CADD 17.80
- A10S (p.Ala10Ser), gnomAD 22-17085119-G-T, REVEL 0.06, MetaLR 0.01
- A10D (p.Ala10Asp), gnomAD 22-17085120-C-A, REVEL 0.09, MetaLR 0.01
- A10V (p.Ala10Val), gnomAD 22-17085120-C-T, REVEL 0.03, MetaLR 0.00
- A10A (p.Ala10Ala), gnomAD 22-17085121-T-C, CADD 6.43
- V11L (p.Val11Leu), TOPMed rs2061321262, REVEL 0.03, MetaLR 0.01
- V11I (p.Val11Ile), gnomAD 22-17085122-G-A, REVEL 0.02, MetaLR 0.01
- V11F (p.Val11Phe), gnomAD 22-17085122-G-T, REVEL 0.03, MetaLR 0.01
- V11A (p.Val11Ala), gnomAD 22-17085123-T-C, REVEL 0.03, MetaLR 0.01
- V11V (p.Val11Val), rs2123786594, gnomAD 22-17085124-C-A, CADD 1.71
- P12L (p.Pro12Leu), TOPMed rs1465825134, gnomAD rs1465825134, REVEL 0.03, MetaLR 0.01
- P12T (p.Pro12Thr), gnomAD rs1483146972, REVEL 0.04, MetaLR 0.02
- P12S (p.Pro12Ser), gnomAD 22-17085125-C-T, REVEL 0.04, MetaLR 0.02
- P12R (p.Pro12Arg), gnomAD 22-17085126-C-G, REVEL 0.02, CADD 8.09
- P12Q (p.Pro12Gln), gnomAD 22-17085126-C-A, REVEL 0.03, CADD 7.68
- P12P (p.Pro12Pro), rs886057200, gnomAD 22-17085127-G-T, CADD 1.44
- G13R (p.Gly13Arg), gnomAD 22-17085128-G-A, REVEL 0.10, CADD 19.00
- G13W (p.Gly13Trp), gnomAD 22-17085128-G-T, REVEL 0.07, CADD 23.20
- G13E (p.Gly13Glu), gnomAD 22-17085129-G-A, REVEL 0.09, CADD 17.40
- G13A (p.Gly13Ala), gnomAD 22-17085129-G-C, REVEL 0.04, CADD 11.60
- G13G (p.Gly13Gly), gnomAD 22-17085130-G-C, CADD 6.64
- P14H (p.Pro14His), Ensembl rs1601332814
- P14R (p.Pro14Arg), rs1601332814, ClinGen CA410210135, ClinVar RCV002966360, AlphaMissense 0.11, MetaLR 0.02, Uncertain significance, Immunodeficiency 51
- P14T (p.Pro14Thr), TOPMed rs1410039989, REVEL 0.02, MetaLR 0.02, Uncertain significance, not specified
- p.Pro14 Gly17del, rs1204898130, gnomAD 22-17085126-CGGGG, CADD 11.80
- P14S (p.Pro14Ser), gnomAD 22-17085131-C-T, REVEL 0.01, CADD 1.16
- P14A (p.Pro14Ala), gnomAD 22-17085131-C-G, REVEL 0.02, CADD 1.04
- P14L (p.Pro14Leu), gnomAD 22-17085132-C-T, REVEL 0.02, CADD 7.33
- P14P (p.Pro14Pro), gnomAD 22-17085133-C-A, CADD 7.02
- L15C (p.Leu15Cys), gnomAD 22-17085126-CG-C, CADD 9.85
- L15L (p.Leu15Leu), rs1481718472, gnomAD 22-17085134-C-T, CADD 6.07
- L15M (p.Leu15Met), gnomAD 22-17085134-C-A, REVEL 0.01, CADD 9.76
- L15P (p.Leu15Pro), gnomAD 22-17085135-T-C, REVEL 0.03, CADD 10.80
- L16R (p.Leu16Arg), ExAC rs752093297, gnomAD rs752093297, REVEL 0.09, MetaLR 0.03
- L16V (p.Leu16Val), gnomAD rs1425048324, REVEL 0.03, MetaLR 0.03
- L16M (p.Leu16Met), gnomAD 22-17085137-C-A, REVEL 0.05, CADD 15.50
- L16L (p.Leu16Leu), gnomAD 22-17085137-C-T, CADD 6.73
- L16P (p.Leu16Pro), gnomAD 22-17085138-T-C, REVEL 0.02, CADD 14.20
- L16Q (p.Leu16Gln), gnomAD 22-17085138-T-A, REVEL 0.05, CADD 21.60
- G17A (p.Gly17Ala), TOPMed rs1568914031, gnomAD rs1568914031, REVEL 0.03, MetaLR 0.02
- G17V (p.Gly17Val), TOPMed rs1568914031, gnomAD rs1568914031, REVEL 0.02, MetaLR 0.02
- G17W (p.Gly17Trp), gnomAD 22-17085140-G-T, REVEL 0.02, CADD 18.70
- G17R (p.Gly17Arg), gnomAD 22-17085140-G-A, REVEL 0.08, CADD 15.20
- G17E (p.Gly17Glu), gnomAD 22-17085141-G-A, REVEL 0.05, CADD 8.96
- p.Gly17 Leu18insPro, gnomAD 22-17085142-G-GCC, CADD 9.26
- G17G (p.Gly17Gly), gnomAD 22-17085142-G-T, CADD 3.90
- L18P (p.Leu18Pro), rs2061321486, ClinGen CA410210155, ClinVar RCV001325608, Ensembl rs2061321486, REVEL 0.05, MetaLR 0.01, Uncertain significance, Immunodeficiency 51
- L18C (p.Leu18Cys), gnomAD 22-17085138-TG-T, CADD 16.80
- L18M (p.Leu18Met), gnomAD 22-17085143-C-A, REVEL 0.02, CADD 9.70
- L18L (p.Leu18Leu), rs2061321477, gnomAD 22-17085143-C-T, CADD 6.56
- L19F (p.Leu19Phe), rs1429270259, ClinGen CA410210159, ClinVar RCV002031566, gnomAD rs1429270259, REVEL 0.03, MetaLR 0.02, Uncertain significance, Immunodeficiency 51
- L19R (p.Leu19Arg), rs937902710, ClinGen CA321139746, ClinVar RCV001236340, TOPMed rs937902710, REVEL 0.16, MetaLR 0.05, Uncertain significance, Immunodeficiency 51
- L19I (p.Leu19Ile), gnomAD 22-17085146-C-A, REVEL 0.04, CADD 13.30
- L19P (p.Leu19Pro), gnomAD 22-17085147-T-C, REVEL 0.15, CADD 22.80
- L19H (p.Leu19His), gnomAD 22-17085147-T-A, REVEL 0.11, CADD 22.50
- L19L (p.Leu19Leu), gnomAD 22-17085148-C-G, CADD 2.13
- L20M (p.Leu20Met), gnomAD 22-17085149-C-A, REVEL 0.07, CADD 22.80
- L20L (p.Leu20Leu), rs1189553717, gnomAD 22-17085149-C-T, CADD 8.16
- L21V (p.Leu21Val), TOPMed rs2061321574, REVEL 0.04, MetaLR 0.03
- p.Leu21 Leu23del, rs751990928, gnomAD 22-17085141-GGCTG, CADD 12.90
- L21L (p.Leu21Leu), gnomAD 22-17085152-C-T, CADD 5.88
- L21R (p.Leu21Arg), rs1172016907, gnomAD 22-17085152-CT-C, CADD 22.60
- L21P (p.Leu21Pro), gnomAD 22-17085153-T-C, REVEL 0.09, CADD 21.20
- L22F (p.Leu22Phe), rs539782982, ClinGen CA321139749, ClinVar RCV001864037, ClinVar RCV004616801, REVEL 0.02, MetaLR 0.02, Uncertain significance, not specified; Immunodeficiency 51
- L22I (p.Leu22Ile), gnomAD 22-17085155-C-A, REVEL 0.01, CADD 7.42
- L22R (p.Leu22Arg), gnomAD 22-17085156-T-G, REVEL 0.12, CADD 14.60
- L22L (p.Leu22Leu), rs781299645, gnomAD 22-17085157-C-T, CADD 5.26
- L23del (p.Leu23del), rs757897521, gnomAD 22-17085148-CCTG-, CADD 13.20
- L23V (p.Leu23Val), gnomAD 22-17085158-C-G, REVEL 0.02, CADD 9.80
- L23L (p.Leu23Leu), gnomAD 22-17085158-C-T, CADD 7.92
- L23M (p.Leu23Met), gnomAD 22-17085158-C-A, REVEL 0.06, CADD 14.20
- L23P (p.Leu23Pro), gnomAD 22-17085159-T-C, REVEL 0.17, CADD 15.90
- G24R (p.Gly24Arg), rs41510847, ClinGen CA10086214, ClinVar RCV000548005, ClinVar RCV004024362, REVEL 0.02, MetaLR 0.01, Uncertain significance, not specified; Immunodeficiency 51
- G24S (p.Gly24Ser), 1000Genomes rs41510847, ExAC rs41510847, TOPMed rs41510847, gnomAD rs41510847, REVEL 0.02, MetaLR 0.01, Uncertain significance
- G24C (p.Gly24Cys), gnomAD 22-17085161-G-T, REVEL 0.02, CADD 13.50
- G24V (p.Gly24Val), gnomAD 22-17085162-G-T, REVEL 0.01, CADD 5.52
- G24D (p.Gly24Asp), gnomAD 22-17085162-G-A, REVEL 0.01, CADD 4.12
- G24G (p.Gly24Gly), rs1216984686, gnomAD 22-17085163-C-T, CADD 10.60
- V25A (p.Val25Ala), gnomAD rs1342472049, REVEL 0.01, MetaLR 0.01
- V25L (p.Val25Leu), rs1297016157, ClinGen CA410210189, ClinVar RCV001038373, ClinVar RCV005851671, REVEL 0.03, MetaLR 0.02, Uncertain significance, Immunodeficiency 51; not specified
- V25M (p.Val25Met), 1000Genomes rs1297016157, TOPMed rs1297016157, gnomAD rs1297016157, REVEL 0.06, MetaLR 0.02, Uncertain significance
- V25E (p.Val25Glu), gnomAD 22-17085165-T-A, REVEL 0.05, CADD 6.41
- V25V (p.Val25Val), rs896285374, gnomAD 22-17085166-G-A, CADD 6.80
- L26P (p.Leu26Pro), TOPMed rs1272018700, gnomAD rs1272018700, REVEL 0.03, MetaLR 0.01
- L26V (p.Leu26Val), TOPMed rs1335482114, gnomAD rs1335482114, REVEL 0.04, MetaLR 0.02
- L26M (p.Leu26Met), gnomAD 22-17085167-C-A, REVEL 0.04, CADD 16.90
- L26L (p.Leu26Leu), gnomAD 22-17085167-C-T, CADD 8.37
- A27D (p.Ala27Asp), rs1490955421, ClinGen CA410210201, ClinVar RCV000803689, TOPMed rs1490955421, REVEL 0.05, MetaLR 0.02, Uncertain significance, Immunodeficiency 51
- A27T (p.Ala27Thr), gnomAD rs1568914083, REVEL 0.06, MetaLR 0.02
- A27V (p.Ala27Val), TOPMed rs1490955421, gnomAD rs1490955421, REVEL 0.03, MetaLR 0.02, Uncertain significance, not specified
- A27S (p.Ala27Ser), gnomAD 22-17085170-G-T, REVEL 0.03, CADD 13.50
- A27A (p.Ala27Ala), rs1222771166, gnomAD 22-17085172-C-T, CADD 11.70
- P28L (p.Pro28Leu), rs1487756841, ClinGen CA410210208, ClinVar RCV002914277, ClinVar RCV004632097, REVEL 0.02, MetaLR 0.03, Uncertain significance, not specified; Immunodeficiency 51
- P28R (p.Pro28Arg), TOPMed rs1487756841, gnomAD rs1487756841, REVEL 0.03, MetaLR 0.02, Uncertain significance
- P28S (p.Pro28Ser), TOPMed rs993343144, gnomAD rs993343144, REVEL 0.01, MetaLR 0.04, Uncertain significance, not specified
- P28T (p.Pro28Thr), TOPMed rs993343144, gnomAD rs993343144, REVEL 0.02, MetaLR 0.04
- P28Q (p.Pro28Gln), gnomAD 22-17085174-C-A, REVEL 0.05, CADD 12.20
- P28P (p.Pro28Pro), rs1188361528, gnomAD 22-17085175-G-A, CADD 12.40
- G29C (p.Gly29Cys), TOPMed rs1026602660, gnomAD rs1026602660, REVEL 0.08, MetaLR 0.09
- G29V (p.Gly29Val), gnomAD rs2061321828, REVEL 0.07, MetaLR 0.08
- G29S (p.Gly29Ser), gnomAD 22-17085176-G-A, REVEL 0.04, CADD 20.60
- G29D (p.Gly29Asp), gnomAD 22-17085177-G-A, REVEL 0.09, CADD 19.30
- G29G (p.Gly29Gly), gnomAD 22-17085178-T-G, CADD 8.69
- G30C (p.Gly30Cys), TOPMed rs1215508376, gnomAD rs1215508376, REVEL 0.01, MetaLR 0.03
- G30S (p.Gly30Ser), TOPMed rs1215508376, gnomAD rs1215508376, REVEL 0.01, MetaLR 0.02
- G30D (p.Gly30Asp), gnomAD 22-17085180-G-A, REVEL 0.03, CADD 15.70
- G30V (p.Gly30Val), gnomAD 22-17085180-G-T, REVEL 0.02, CADD 14.50
- G30G (p.Gly30Gly), gnomAD 22-17085181-C-T, CADD 13.40
- A31T (p.Ala31Thr), TOPMed rs1601332920, gnomAD rs1601332920, REVEL 0.04, MetaLR 0.05
- A31D (p.Ala31Asp), gnomAD 22-17085179-GGCGC, CADD 24.10
- A31S (p.Ala31Ser), gnomAD 22-17085182-G-T, REVEL 0.01, CADD 16.30
- A31V (p.Ala31Val), gnomAD 22-17085183-C-T, REVEL 0.04, CADD 22.60
- A31A (p.Ala31Ala), rs1449112570, gnomAD 22-17085184-C-T, CADD 14.20
- S32A (p.Ser32Ala), TOPMed rs1346925760, gnomAD rs1346925760, REVEL 0.04, MetaLR 0.04, Uncertain significance, Immunodeficiency 51
- S32C (p.Ser32Cys), TOPMed rs1167001946, gnomAD rs1167001946, REVEL 0.06, MetaLR 0.07
- S32F (p.Ser32Phe), TOPMed rs1167001946, gnomAD rs1167001946, REVEL 0.04, MetaLR 0.07
- S32P (p.Ser32Pro), gnomAD 22-17085185-T-C, REVEL 0.05, CADD 22.90
- S32Y (p.Ser32Tyr), gnomAD 22-17085186-C-A, REVEL 0.05, CADD 23.40
- S32S (p.Ser32Ser), rs1460478686, gnomAD 22-17085187-C-A, CADD 10.40
- L33M (p.Leu33Met), gnomAD 22-17085188-C-A, REVEL 0.05, CADD 21.30
- L33L (p.Leu33Leu), rs2061321924, gnomAD 22-17085188-C-T, CADD 11.20
- L33Q (p.Leu33Gln), gnomAD 22-17085189-T-A, REVEL 0.13, CADD 22.60
- L33R (p.Leu33Arg), gnomAD 22-17085189-T-G, REVEL 0.14, CADD 22.70
- L33P (p.Leu33Pro), gnomAD 22-17085189-T-C, REVEL 0.03, CADD 15.80
- R34R (p.Arg34Arg), rs1387278734, gnomAD 22-17085191-C-A, CADD 11.60
- R34* (p.Arg34Ter), gnomAD 22-17085191-C-T, CADD 37.00
- R34L (p.Arg34Leu), gnomAD 22-17085192-G-T, REVEL 0.10, CADD 25.20
- R34Q (p.Arg34Gln), gnomAD 22-17085192-G-A, REVEL 0.06, CADD 23.70
- L35F (p.Leu35Phe), gnomAD 22-17085194-C-T, REVEL 0.06, CADD 22.30
- L35P (p.Leu35Pro), gnomAD 22-17085195-T-C, REVEL 0.24, CADD 25.60
- L35L (p.Leu35Leu), rs887188602, gnomAD 22-17085196-C-G, CADD 9.08
- L36V (p.Leu36Val), rs2061321959, ClinGen CA410210249, ClinVar RCV001348959, ClinVar RCV005851851, REVEL 0.08, MetaLR 0.10, Uncertain significance, not specified; Immunodeficiency 51
- L36L (p.Leu36Leu), gnomAD 22-17085197-C-T, CADD 7.37
- L36M (p.Leu36Met), gnomAD 22-17085197-C-A, REVEL 0.10, CADD 17.90
Public IL17RA analysis runs
- IL17RA analysis run — IL17RA (1,432 variants) — completed 2026-08-19